Opioid Relapse Reduction Therapeutics Grant

Funding Agency:
Brain Research Foundation

The purpose of this request for proposals is to support the development of novel, translational research that will help accelerate the understanding of the mechanisms associated with opioid use disorders and addiction, targeted to medication development for new relapse reduction therapeutics.

The pre-clinical research areas of focus may include (but are not limited to):

  • Neurobiology of relapse to drug taking
  • Identifying new chemicals for high potential for relapse reduction
  • Repurposing of FDA-approved therapies for relapse reduction
  • Alternative therapies
  • Vulnerability to relapse factors (e.g., genetics, epigenetics, environmental stresses)

Deadline for Letter of Intent: Feb. 28, 2018

Agency Website

Eligibility Requirements

To be eligible, the PI must be a full-time tenure-track or tenured faculty at a U.S. institution, working in the area of study of opioid addiction. The goal of this program is to accelerate the development of new relapse reduction therapeutics.



Amount Description

Based on the quality of applications, Brain Research Foundation will fund up to 2 grants on opioid relapse reduction research. Each total award is limited to $50,000 (direct costs) for a one year grant period from the specified dates only. Dates will be provided by BRF upon application approval.

Funding Type



Junior Faculty


Medical - Translational

External Deadline

February 28, 2018